Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W7DD
|
|||
| Former ID |
DIB012503
|
|||
| Drug Name |
BAY-44-3428
|
|||
| Synonyms |
APC-1167
Click to Show/Hide
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Terminated | [1] | |
| Company |
Celera South San Francisco
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tryptase alpha/beta-1 (Tryptase) | Target Info | Inhibitor | [2] |
| Reactome | Activation of Matrix Metalloproteinases | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010843) | |||
| REF 2 | Bayer AG to Develop Arris Asthma Compound; Arris to Receive Milestone Payment. 1996 Business Wire | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.